Both loss-of-function and gain-of-function studies have shown that PGC-1α over expression results in hepatic insulin resistance, while PGC-1α deficiency is accompanied by alterations in hepatic energy and lipid metabolism, lipid accumulation (steatosis), insulin signaling and diminished hepatic gluconeogenesis [33-35]. This evidence concerns the gene PPARGC1A and steatosis.